Compare PSTV & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSTV | ORIO |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | Canada |
| Employees | N/A | 178 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 27.1M |
| IPO Year | 2016 | N/A |
| Metric | PSTV | ORIO |
|---|---|---|
| Price | N/A | $0.94 |
| Analyst Decision | | |
| Analyst Count | | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | 46.3K |
| Earning Date | 04-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $78.15 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | $4.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $0.90 |
| 52 Week High | N/A | $1.40 |
| Indicator | PSTV | ORIO |
|---|---|---|
| Relative Strength Index (RSI) | 96.29 | 34.57 |
| Support Level | $0.37 | N/A |
| Resistance Level | N/A | $1.27 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 93.21 | 19.51 |
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Orion Digital Corp is a digital finance company operating across wealth, payments, and digital assets. Through its Investing wealth platform, Carta World-wide payments infrastructure, and long-duration Bitcoin treasury plan - combined with a disciplined, multi-engine compounding model. Orion Digital is focused on compounding value through execution, scale, and capital discipline.